NCT03737305

Brief Summary

Articular Disc Displacements are the most common TMJ arthropathy and the articular distraction technique is one of the most common therapeutic resources. It is a technique almost exclusively performed by the physiotherapist and / or dentist, with repeated applications over an extended period of treatment, that can reach several weeks or months, difficult to perform manually by the patient on an ambulatory basis. Currently there are no ambulatory mandibular exercise devices that aim to execute articular distraction. Thus, the objective of this work was to study, design and develop a device capable of performing and / or assisting patients in the articular distraction maneuver.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 3, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 9, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
Last Updated

November 13, 2018

Status Verified

November 1, 2018

Enrollment Period

1.1 years

First QC Date

November 3, 2018

Last Update Submit

November 8, 2018

Conditions

Keywords

TMJDisc DisplacementTemporomandibular DisordersTMJ Distraction DeviceTMJ Pain

Outcome Measures

Primary Outcomes (3)

  • Change of Pain at Rest (Visual Analogic Scale from 0-10)

    Mandibular Pain at Rest evaluated in a 0-10 (VAS) Visual Analogic Scale being 0 ´´No pain´´ and 10 ´´The worst pain ever´´

    0 day, 7 days, 14 days, 28 days and 90 days of the study

  • Change of Pain in Function (Visual Analogic Scale from 0-10)

    Mandibular Pain in Function evaluated in a 0-10 (VAS) Visual Analogic Scale being 0 ´´No pain´´ and 10 ´´The worst pain ever´´

    0 day, 7 days, 14 days, 28 days and 90 days of the study

  • Change of Subjective chewing efficiency

    Subjective chewing efficiency (evaluated in a 0-10 Visual Analogic Scale with 0 being ´´the worst efficiency ever´´ and 10 ´´the best efficiency ever´´)

    0 day, 7 days, 14 days, 28 days and 90 days of the study

Secondary Outcomes (2)

  • Change in the Perceived subjective treatment effectiveness

    0 day, 7 days, 14 days, 28 days and 90 days of the study

  • Change of Jaw range of motion function in millimetres

    0 day, 7 days, 14 days, 28 days and 90 days of the study

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Control group of conventional therapy with manual distraction performed by the physiotherapist in the office (active comparator)

Device: Conventional Physical Therapy

Distractor Test Group

EXPERIMENTAL

Test group with manual distraction performed by the physiotherapist in the office and the condylar distraction performed by the patient with the condylar distraction device in an ambulatory basis.

Device: TMJ Condilar Distraction Device

Interventions

The patients will perform condylar distraction with the condylar distraction device in an ambulatory basis.

Distractor Test Group

Conventional Physical Therapy, performed in office by a experienced physical therapist for the TMJ condition.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a minimum of 18 years of age
  • Diagnosis by the Research Diagnostic criteria of Temporomandibular Disorders (RDC / TMD), of disk displacement with or without reduction, with or without opening limitation (Group IIa, IIb or IIc) and atralgia (Group IIIa)
  • Clinical indication for the proposed treatment

You may not qualify if:

  • Patients \<18 years
  • Pregnant patients
  • Absence of posterior teeth (not rehabilitated), advanced periodontal disease in the posterior teeth or patients with total dentures that compromise the use of the device
  • Diagnosis by the Research Diagnostic criteria of Temporomandibular Disorders (RDC / TMD), of Osteoarthritis (Group IIIb) and Osteoarthrosis (IIIc)
  • Presence of contralateral TMJ pathology, with no clinical indication for the proposed treatment, limiting the patient's mandibular mobility and influencing patient rehabilitation (eg, ankylosis or myofibrotic contracture)
  • History of surgery at the ATM
  • Patients with systemic disease that may affect the TMJ
  • Aphasia, dementia, or known psychiatric or physical comorbidity that may interfere with communication or compliance during the rehabilitation process.
  • Patients blind, illiterate or with reduced cognitive abilities that may interfere with communication or compliance during the rehabilitation process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OrisClinic - Júlio Fonseca

Coimbra, 3000-041, Portugal

RECRUITING

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Officials

  • Júlio Fonseca

    Dr.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Júlio Fonseca, Dr.

CONTACT

Júlio André Fonseca, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The Outcomes Assessor, or secondary investigator does nor have the knowlegde of the group of patients that is being evaluated.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a randomized controlled clinical trial, in a unique investigation center, non-blinded, parallel-group, comparative and interpretive study of the results of clinical use of a TMJ distraction device in patients with diagnosis of Articular Disorders, compared to the traditional method of treatment using manual physiotherapy.
Sponsor Type
INDIV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor (Dentistry); Principal Investigator

Study Record Dates

First Submitted

November 3, 2018

First Posted

November 9, 2018

Study Start

May 1, 2018

Primary Completion

June 1, 2019

Study Completion

June 30, 2019

Last Updated

November 13, 2018

Record last verified: 2018-11

Locations